Clinical Trial

oCular Examination at Cell RESolution With Optical TransmissionTomography

Study acronym: CERES-OTT
Recruiting
View on ClinicalTrials.gov →
Summary
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transmission tomography (OTT), which enables imaging of the anterior parts of the eye with high cellular resolution, a wide field of view and reduced examination delay.
Trial Details
NCT Number NCT06976034
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions Glaucoma Associated With Other Ocular Disorders
Enrollment 300 participants
Start Date 2024-11-12
Primary Completion 2029-11-12 (estimated)
Study Completion 2029-11-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-16